Sulfasalazine vs placebo
Remission · patients with Induction of remission or response in Crohn's disease
Sulfasalazine showed no clear difference in induction of remission (CDAI <150) (Random Effects Model) compared with placebo (moderate certainty).
1 finding from 1 review
- Aminosalicylates for induction of remission or response in Crohn's disease 2016 · Cochrane Headline outcomes onlyRR 1.38 [1, 1.89]2 studies · 263 participantsModerate